GVR Report cover Skin Antiseptic Products Market Size, Share & Trends Report

Skin Antiseptic Products Market Size, Share & Trends Analysis Report By Formulations (Alcohols, Chlorhexidine), By Type (Solutions, Swab Sticks, Wipes), By Application (Surgeries, Injections), By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-2-68038-930-2
  • Number of Pages: 132
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Report Overview

The global skin antiseptic products market size was valued at USD 252.22 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.9% from 2022 to 2030. Demand for skin antiseptic products market is increasing due to the rising prevalence of hospital-acquired diseases or hospital-acquired infection (HAI), and the growing use of surgical units along with endoscope reprocesses. Increasing cases of hospital-acquired infections due to lack of sanitation & precaution are among the major factors contributing to the market growth. According to the Centers for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one healthcare-associated infection, on any given day. This is expected to boost the demand for skin antiseptic products.

U.K. skin antiseptic products market size, by formulation, 2020 - 2030 (USD Million)

The application of antiseptics generally provides protection against contamination and lowers the risk of getting hospital-acquired infections. Moreover, it prevents bacteria, viruses, or other microbes that cause diseases from entering a patient’s body. Thus, such solutions are widely required in hospitals to maintain proper hygiene & sanitation, as well as to lower the risk of hospital-acquired infections. Therefore, this factor is expected to propel market growth during the forecast period.

The growing rate of endoscopy is also expected to increase the risk of getting hospital-acquired infections. In such cases, proper application of antiseptic & disinfectant solutions is imperative to prevent the transmission of infections. The rise in the number of COVID-19 patients was expected to lower the growth rate of the skin antiseptic products demand; however, the reduction in cases of COVID-19 due to the onset of vaccination is anticipated to increase the need for skin antiseptic products. An increase in the number of vaccinations is leading to the augmented use of injections, thereby impelling the skin antiseptic product market growth.

Moreover, to cope with the increasing demand, companies in the market are entering into strategic initiatives, such as product launches, geographical expansion, mergers, acquisitions, and partnerships. For instance, in February 2021, Avrio Health announced the launch of Betadine, Similarly, to increase its reach, Cardinal Health announced the addition of a new distribution center in Columbus, Ohio. Thus, the above-mentioned factors are anticipated to propel the skin antiseptic products market demand during the post-pandemic period.

Formulation Insights

The alcohols segment dominated the skin antiseptic products market in 2021, owing to increasing usage for pre-injection and pre-operative skin preparation. Furthermore, the growing demand for alcohol base to be used in combination with other formulations, such as iodine and chlorhexidine, is fueling the segment growth. In addition, alcohol skin antiseptic products comprise antiseptic agents, such as isopropyl or ethyl. These are effective against numerous microbes.

The octenidine skin antiseptic products market is anticipated to witness the fastest growth of 7.5% during the forecast period. It is an internal substitute for chlorhexidine and iodine skin antiseptic products. Moreover, in countries such as the U.S., the FDA has restricted the use of chlorhexidine & iodine. This may help in the growth of the market for alternatives such as octenidine.

Type Insights

Based on the type of skin antiseptic products, solutions were the highest revenue-generating segment with a market share of 48.44% in 2021. This can be accredited to the high prevalence of hospital-acquired infections & SSIs and the easy availability of numerous solutions in the market. Moreover, growing awareness and increasing applications of antiseptic solutions in pre-operation and pre-injection skin preparation are impelling the market. Antiseptic solutions significantly reduce the contamination risk and transmission of infections.

In addition, rising cases of hospital-acquired infections have led to a growth in the usage of antiseptics for surgeries. For instance, as per NCBI, approximately, 1.7 million hospitalizations initiate hospital-acquired infections annually.  Similarly, according to an article by European Center for Disease Prevention and Control in 2018, around 8.9 million HAIs were estimated to arise every year in European long-term care facilities and hospitals. Therefore, due to the above-mentioned factors, the solution segment is predicted to witness significant growth throughout the forecast period.

However, the wipes segment is anticipated to witness the fastest CAGR of 7.2% during the forecast period. Wipes are easy to use, which helps in film and tape adhesion. Furthermore, wipes are extremely effective for wound application, as they completely clean the wound area, leaving behind no residue.

Application insights

The injection segment dominated the skin antiseptic products market in 2021 with a market share of 90.17% and is anticipated to witness the fastest growth throughout the forecast period. The growth of the segment is attributable to the increasing use of joint injections for extracting fluid from swollen joints for injecting medicines. The growing geriatric population and individuals suffering from joint injuries and sports-related wounds respectively are the primary users of these injections. Furthermore, joint injections carrying zero side effects are gaining popularity among patients, which is again expected to expand the market considerably during the forecast period.

Global skin antiseptic products market share, by application, 2021 (%)

The surgeries segment is anticipated to witness a significant CAGR of 6.5% during the forecast period. The growth rate can be credited to the globally rising number of surgical cases. For instance, as per the Aesthetics Society, 252,022 breast augmentations, 296,601 liposuctions, and 163,073 abdominoplasty surgeries were recorded in the year 2020, thus helping the segment growth.

Regional Insights

North America dominated the global skin antiseptic products market in 2021 and is expected to lead the market throughout the forecast period. The rising number of surgeries in this region is one of the major drivers positively impacting the market growth. Preoperative skin preparation is one of the essential steps adopted by surgeons before surgical treatments. Thus, the demand for skin-antiseptic products is anticipated to rise with the increasing rate of surgical actions.

Asia-Pacific skin antiseptic products market is expected to witness the fastest growth rate of 7.4% during the forecast period. Increasing healthcare expenditure by the public and private sectors is one of the major driving factors for the market. Such a scenario is anticipated to encourage several major and local players to enter in the market, due to which growth is expected.

Key Companies & Market Share Insights

Key players have taken strategic initiatives, such as partnerships, mergers & acquisitions, and product launches, in order to sustain in the market. For instance, in February 2019, Schülke & Mayr signed a distribution agreement with DKSH, one of the leading market expansion service providers. Under this agreement, DKSH will distribute and market a wide range of Schülke’s disinfectant products in China. Some of the prominent players in the global skin antiseptic products market include:

  • 3M

  • Ecolab

  • BD

  • Sage Products LLC

  • B.Braun

  • Melsungen AG

  • Johnson & Johnson

  • Schulke & Mayr GmbH 

Skin Antiseptics Products Market Report Scope

Report Attribute


Market size value in 2022

USD 279.96 million

Revenue forecast in 2030

USD 478.35 million

Growth Rate

CAGR of 6.9% from 2022 to 2030

Base year for estimation


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million,  CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Formulation, type, application

Regional scope

North America, Europe, Asia Pacific, Latin America,  Middle East & Africa (MEA)

Country scope

U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, Colombia, South Africa, Saudi Arabia, UAE

Key companies profiled

3M; Ecolab; BD; Sage Products LLC; B.Braun Melsungen AG; Schulke & Mayr GmbH; Cardinal Health; Smith & Nephew; Avrio Health; Microgen.

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global skin antiseptic products market report based on the formulation, type, application, and region:

  • Formulation Outlook (Revenue, USD Million, 2018 - 2030)

    • Alcohols

    • Chlorhexidine

    • Iodine

    • Octenidine 

    • Others

  • Type Outlook (Revenue, USD Million, 2018 - 2030)

    • Solutions

    • Swab Sticks

    • Wipes

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Surgeries

      • Spinal

      • Joints

      • Others

    • Injections

      • Spinal

      • Joints

      • Others

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon